Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate-2,2,3,3,4,4,5,5,6,6-d10 hydrochloride
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Yes -Refer MSDS for accurate information
Irinotecan-d10 Hydrochloride is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Irinotecan-d10 Hydrochloride usage and description
Irinotecan D10 Hydrochloride is a potent chemotherapy drug used to treat various types of cancer including colon, rectal, and lung cancers. The chemical name for Irinotecan D10 Hydrochloride is (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrido[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate hydrochloride. The D10 in the name indicates that the drug contains ten deuterium atoms, which are stable isotopes of hydrogen.
Irinotecan D10 Hydrochloride works by inhibiting the activity of topoisomerase I, an enzyme that is necessary for DNA replication and repair. By blocking this enzyme, the drug prevents cancer cells from dividing and multiplying, ultimately leading to their death.
The drug is administered intravenously and its dosage varies depending on the type of cancer being treated and the patient's individual response to the drug. Irinotecan D10 Hydrochloride is metabolized in the liver and excreted in the urine and feces.
Like most chemotherapy drugs, Irinotecan D10 Hydrochloride has several potential side effects, including nausea, vomiting, diarrhea, and hair loss. It can also cause a decrease in white blood cell count, which increases the risk of infections. Patients undergoing treatment with Irinotecan D10 Hydrochloride should be closely monitored by their healthcare provider to manage any side effects and ensure the drug is effectively treating their cancer.
